Drugs / EBRRM
last change Aug 2022 re-read 2 minutes ago

EBRRM

Developed for
pulpitis

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT05853185 Comparator Oct 2021 → May 2022 pulpitis Liaquat University of Medical & Health Sciences Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as EBRRM ClinicalTrials.gov intervention name — accepted as the source's own label NCT05853185